tiprankstipranks
Trending News
More News >
Abattis Bioceuticals Corp (ATTBF)
OTHER OTC:ATTBF
US Market

Abattis Bioceuticals (ATTBF) Ratios

Compare
175 Followers

Abattis Bioceuticals Ratios

ATTBF's free cash flow for Q4 2019 was C$0.72. For the 2019 fiscal year, ATTBF's free cash flow was decreased by C$ and operating cash flow was C$-3.93. See a summary of the company’s cash flow.
Ratios
TTM
Dec 19Dec 18Dec 17Dec 16
Liquidity Ratios
Current Ratio
0.73 0.73--
Quick Ratio
0.68 0.68--
Cash Ratio
0.41 0.41--
Solvency Ratio
-0.34 -0.34--
Operating Cash Flow Ratio
1.92 1.92--
Short-Term Operating Cash Flow Coverage
6.64 6.64--
Net Current Asset Value
C$ -4.99MC$ -4.99M--
Leverage Ratios
Debt-to-Assets Ratio
0.08 0.08--
Debt-to-Equity Ratio
0.14 0.14--
Debt-to-Capital Ratio
0.12 0.12--
Long-Term Debt-to-Capital Ratio
0.00 0.00--
Financial Leverage Ratio
1.74 1.74--
Debt Service Coverage Ratio
-2.62 -2.68--
Interest Coverage Ratio
-80.16 -80.16--
Debt to Market Cap
70.54 0.13--
Interest Debt Per Share
<0.01 <0.01--
Net Debt to EBITDA
0.12 0.12--
Profitability Margins
Gross Profit Margin
67.62%67.62%--
EBIT Margin
-843.89%-843.89%--
EBITDA Margin
-1078.19%-1078.19%--
Operating Profit Margin
-1108.73%-1108.73%--
Pretax Profit Margin
-857.72%-857.72%--
Net Profit Margin
-852.40%-852.40%--
Continuous Operations Profit Margin
-857.72%-857.72%--
Net Income Per EBT
99.38%99.38%--
EBT Per EBIT
77.36%77.36%--
Return on Assets (ROA)
-15.79%-15.79%--
Return on Equity (ROE)
-26.96%-27.46%--
Return on Capital Employed (ROCE)
-27.58%-27.58%--
Return on Invested Capital (ROIC)
-25.05%-25.78%--
Return on Tangible Assets
-68.98%-68.98%--
Earnings Yield
-15358.89%-26.98%--
Efficiency Ratios
Receivables Turnover
2.30 2.30--
Payables Turnover
0.53 0.53--
Inventory Turnover
0.43 0.43--
Fixed Asset Turnover
0.47 0.47--
Asset Turnover
0.02 0.02--
Working Capital Turnover Ratio
0.08 0.08--
Cash Conversion Cycle
310.19 310.19--
Days of Sales Outstanding
158.61 158.61--
Days of Inventory Outstanding
846.07 846.07--
Days of Payables Outstanding
694.49 694.49--
Operating Cycle
1.00K 1.00K--
Cash Flow Ratios
Operating Cash Flow Per Share
0.02 0.02--
Free Cash Flow Per Share
<0.01 <0.01--
CapEx Per Share
0.01 0.01--
Free Cash Flow to Operating Cash Flow
0.46 0.46--
Dividend Paid and CapEx Coverage Ratio
1.86 1.86--
Capital Expenditure Coverage Ratio
1.86 1.86--
Operating Cash Flow Coverage Ratio
6.00 6.00--
Operating Cash Flow to Sales Ratio
26.37 26.37--
Free Cash Flow Yield
21633.37%38.59%--
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -3.71--
Price-to-Sales (P/S) Ratio
0.06 31.59--
Price-to-Book (P/B) Ratio
<0.01 1.02--
Price-to-Free Cash Flow (P/FCF) Ratio
<0.01 2.59--
Price-to-Operating Cash Flow Ratio
<0.01 1.20--
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.04--
Price-to-Fair Value
<0.01 1.02--
Enterprise Value Multiple
0.11 -2.81--
Enterprise Value
-429.73K 10.83M--
EV to EBITDA
0.11 -2.81--
EV to Sales
-1.20 30.33--
EV to Free Cash Flow
-0.10 2.49--
EV to Operating Cash Flow
-0.05 1.15--
Tangible Book Value Per Share
>-0.01 >-0.01--
Shareholders’ Equity Per Share
0.02 0.02--
Tax and Other Ratios
Effective Tax Rate
0.00 -0.03--
Revenue Per Share
<0.01 <0.01--
Net Income Per Share
>-0.01 >-0.01--
Tax Burden
0.99 0.99--
Interest Burden
1.02 1.02--
Research & Development to Revenue
0.00 0.00--
SG&A to Revenue
8.34 8.34--
Stock-Based Compensation to Revenue
<0.01 <0.01--
Income Quality
-3.07 -3.07--
Currency in CAD